|  Help  |  About  |  Contact Us

Publication : Skin allograft rejection and hyperbaric oxygen treatment in immune-histoincompatible mice.

First Author  Erdmann D Year  1995
Journal  Undersea Hyperb Med Volume  22
Issue  4 Pages  395-9
PubMed ID  8574127 Mgi Jnum  J:30372
Mgi Id  MGI:77885 Citation  Erdmann D, et al. (1995) Skin allograft rejection and hyperbaric oxygen treatment in immune-histoincompatible mice. Undersea Hyperb Med 22(4):395-9
abstractText  The effect of hyperbaric oxygen (HBO) as an immunosuppressive agent was evaluated by using a highly immunogenic skin allograft mouse model. Immune-histoincompatible female C57BL/6 and BALB/c mice (N = 30) were randomly assigned to three groups receiving no treatment (control group), low dose HBO treatment (two treatments once a week), and intermediate HBO treatment (two treatments 3 times/wk) 1 wk before and 2 wk after transplantation of a 1.5 x 2 cm full thickness skin allograft from the back. Rejection was observed a Day 7 and was completed 14 days after surgery in controls. Low dose and intermediate HBO treatment delayed skin allograft rejection, which was histologically confirmed.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

0 Bio Entities

0 Expression